• Israfan
  • Posts
  • Israel’s golden opportunity to reduce reliance on US military aid

Israel’s golden opportunity to reduce reliance on US military aid

Recent challenges highlight why a more independent defense strategy may better serve Israel’s long-term interests.

Israel’s longstanding reliance on U.S. military aid is coming under increasing scrutiny as the Jewish state evaluates its strategic and economic future. While the aid currently set at $3.8 billion annually has enabled Israel to maintain its qualitative military edge, recent challenges in obtaining critical resupplies during wartime have revealed its limitations.

The aid comes primarily through the U.S. Foreign Military Financing (FMF) program, under which Israel receives $3.3 billion in annual grants to purchase American-made military equipment, along with $500 million for missile defense. However, analysts and experts now argue that this dependency may be more costly than beneficial in the long run.

Recent delays in resupplying essential materials, such as bombs and armored tractors, have raised concerns. Reports of conditions tied to aid such as demands to adjust Israel’s humanitarian policies in Gaza have underscored how reliance on foreign support can be leveraged politically.

Raphael BenLevi of the Misgav Institute for National Security and Zionist Strategy describes the dynamic as an “unhealthy dependency” that hinders Israel’s autonomy. “What has become clear is the fact that Israel has not maintained its own independent arms manufacturing for bombs and the like. It has become dependent on resupply on a monthly and even weekly basis,” BenLevi said.

U.S. military aid once represented a significant share of Israel’s economy, accounting for 5.7% of its Gross National Product (GNP) in 1995. Today, that figure has dropped to just 0.7%, reflecting Israel’s economic growth and resilience.

This shift opens the door for Israel to gradually phase out aid without sacrificing security. “Israel is definitely capable of drawing down its dependency over a 10-year period,” BenLevi argues, noting that such a transition would enhance Israel’s independence without undermining the U.S.-Israel relationship.

The upcoming renegotiation of the Memorandum of Understanding (MOU) on U.S. military aid provides a pivotal opportunity for Israel to chart a new course. With a second Trump administration expected to prioritize strong, self-reliant allies, analysts believe this could align with Israeli goals.

Gideon Israel, president of the Jerusalem-Washington Center, calls this “a golden opportunity” to redefine the aid framework. “Under Trump, the shift won’t be seen as a weakening of the alliance but as a move toward a more balanced and reciprocal partnership,” he said.

Reducing dependency on U.S. aid could have far-reaching benefits. It would strengthen Israel’s deterrence by signaling to allies and adversaries alike that it is capable of acting decisively without foreign approval. Furthermore, maintaining greater control over its defense strategy could allow Israel to revisit its security doctrine, shifting from defensive postures like missile systems to holding strategic territory, thereby reducing long-term risks.

The U.S. would also continue to benefit from its partnership with Israel. American defense companies have long relied on Israel as a proving ground for their technologies, with Israeli innovations enhancing platforms like the F-35 fighter jet.

While U.S. military aid has undeniably bolstered Israel’s security for decades, the time may have come for Israel to step into a more independent role. By gradually reducing reliance on external funding, Israel can better safeguard its sovereignty, improve its strategic position, and redefine its relationship with its closest ally.

As BenLevi concludes, “The advantages of independence and moving to a more reciprocal relationship with Washington clearly outweigh the benefits of continuing the status quo.”

Share this article or subscribe to our newsletter to stay informed about Israel’s evolving defense strategies.